HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Unilever restructuring: Chese-Pond's to control Lever Bros. body wash products.

This article was originally published in The Rose Sheet

Executive Summary

CHESE-POND'S TO OVERSEE LEVER BROS. BODY WASH BRANDS UNDER RESTRUCTURING announced by Unilever on Sept. 25. Effective Oct. 1, the operations of Chesebrough Pond's, Lever Brothers and Helene Curtis will be consolidated into a single company, the Unilever Home and Personal Care USA, to be headed by Unilever Home and Personal Care North America President Robert Phillips.

You may also be interested in...

Unilever Appoints Strauss Personal Care President, Succeeding Phillips

Unilever's home and personal care business group will be headed by Latin America President Charles Strauss, following the retirement of Robert Phillips. Strauss assumes his new responsibilities Sept. 1.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts